
Fragile X Syndrome and Molecular Testing
The Ateneo Autism Study Group (AASG) conducts the first molecular testing for Fragile X Syndrome (FXS) in the Philippines! Identifying a genetic cause for ASD may help foresee and support diagnosis to identify additional family members who could benefit from targeted treatment. Currently, there are multiple drug trials that aim to address the cellular and behavioral concerns seen in FXS, aiming to improve the developmental trajectories caused by the mutation in FMR1 gene.
-
MIND Plug-in: Development of an Electronic Medical Record based data collection tool for research in autism and neurodevelopmental disorders
This paper describes the efforts to support capacity building efforts for conducting research in autism in the Philippines.
-
Evaluation of the Clinical Outcomes of the Early Start Denver Model: Philippine Revised (ESDM-PR) for Toddlers with Autism Spectrum Disorder
The main objective of this research study is to measure the effectiveness of the Early Start Denver Model: Philippine Revised program in the management of Filipino toddlers with ASD.